NEXTPHARMA TECHNOLOGIES HOLDING LIMITED

Active London

Activities of head offices

4 employees website.com
Life sciences and medical technology Activities of head offices
N

NEXTPHARMA TECHNOLOGIES HOLDING LIMITED

Activities of head offices

Founded 2 Jan 2003 Active London, England 4 employees website.com
Life sciences and medical technology Activities of head offices
Accounts Submitted 4 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 7 Jan 2026 Next due 16 Jan 2027 7 months remaining
Net assets £-46M £37M 2024 year on year
Total assets £20M £35M 2024 year on year
Total Liabilities £66M £2M 2024 year on year
Charges 8
1 outstanding 7 satisfied

Contact & Details

Contact

Registered Address

83 Victoria Street London SW1H 0HW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEXTPHARMA TECHNOLOGIES HOLDING LIMITED (04627290), an active life sciences and medical technology company based in London, England. Incorporated 2 Jan 2003. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£133.92k

Increased by £47.97k (+56%)

Net Assets

-£46.04M

Decreased by £36.54M (-384%)

Total Liabilities

£65.67M

Increased by £1.71M (+3%)

Turnover

£1.37M

Increased by £168.00k (+14%)

Employees

4

Debt Ratio

335%

Increased by 218 (+186%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 7,496,785,118 Shares £74.97m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Nov 20177,496,785,118£74.97m£0.01

Officers

Officers

2 active 1 resigned
Status
Alan Jonathan DodsworthSecretaryUnknownUnknown4 Apr 2011Active
Peter Arend William BuremaDirectorDutchNetherlands6710 Jun 2014Active

Shareholders

Shareholders (1)

Nextpharma Holdings Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Seamus Philip Fitzpatrick

British,irish

Active
Notified 2 Jan 2019
Residence United Kingdom
DOB November 1966
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 7 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Jan 2026Confirmation StatementConfirmation statement made on 2 Jan 2026 with no updates
3 Jan 2026OfficersTermination of Peter Arend William Burema as director on 1 Nov 2025
27 Dec 2025OfficersAppointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025
4 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
29 Jan 2025OfficersChange to director Mr Peter Arend William Burema on 27 Jan 2025
7 Jan 2026 Confirmation Statement

Confirmation statement made on 2 Jan 2026 with no updates

3 Jan 2026 Officers

Termination of Peter Arend William Burema as director on 1 Nov 2025

27 Dec 2025 Officers

Appointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025

4 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 Jan 2025 Officers

Change to director Mr Peter Arend William Burema on 27 Jan 2025

Recent Activity

Latest Activity

Confirmation statement made on 2 Jan 2026 with no updates

4 months ago on 7 Jan 2026

Termination of Peter Arend William Burema as director on 1 Nov 2025

4 months ago on 3 Jan 2026

Appointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025

5 months ago on 27 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 4 Oct 2025

Change to director Mr Peter Arend William Burema on 27 Jan 2025

1 years ago on 29 Jan 2025